Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C11H15NO.ClH |
| Molecular Weight | 213.704 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.C[C@H]1NCCO[C@@H]1C2=CC=CC=C2
InChI
InChIKey=VJNXVAVKCZJOFQ-XQKZEKTMSA-N
InChI=1S/C11H15NO.ClH/c1-9-11(13-8-7-12-9)10-5-3-2-4-6-10;/h2-6,9,11-12H,7-8H2,1H3;1H/t9-,11+;/m1./s1
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C11H15NO |
| Molecular Weight | 177.2429 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Phenmetrazine is an anti-obesity drug, which was discovered by Boehringer-Ingelheim in 1952 and approved by FDA under the name Preludin. Later on the drug was withdrawn from the market due to the reported cases of abuse. According to some studies, misuse of phenmetrazine turned many young addicts to crime. It is suggested that the drug exerts its effect by inhibiting the monoamine transport.
CNS Activity
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P31645 Gene ID: 6532.0 Gene Symbol: SLC6A4 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17017961 |
7765.0 nM [EC50] | ||
Target ID: Q01959 Gene ID: 6531.0 Gene Symbol: SLC6A3 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17017961 |
131.0 nM [EC50] | ||
Target ID: P23975 Gene ID: 6530.0 Gene Symbol: SLC6A2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/17017961 |
50.4 nM [IC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseTreatment of obesity. |
Cmax
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
120 μg/L EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6026786/ |
75 mg single, oral dose: 75 mg route of administration: Oral experiment type: SINGLE co-administered: |
PHENMETRAZINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
8 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6026786/ |
75 mg single, oral dose: 75 mg route of administration: Oral experiment type: SINGLE co-administered: |
PHENMETRAZINE plasma | Homo sapiens population: HEALTHY age: ADULT sex: FEMALE / MALE food status: FASTED |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Selective suppression of cocaine- versus food-maintained responding by monoamine releasers in rhesus monkeys: benzylpiperazine, (+)phenmetrazine, and 4-benzylpiperidine. | 2009-04 |
|
| Nontraumatic rhabdomyolysis and acute renal failure associated with oral phenmetrazine hydrochloride. | 1984-02 |
|
| Rhabdomyolysis and shock after intravenous amphetamine administration. | 1977-04 |
|
| [Psychotic syndromes in phenmetrazine addiction]. | 1972-01-15 |
|
| [Psychoses induced by chronic administration of barbiturates in combination with phenmetrazine]. | 1971-10 |
|
| [Mental disorders caused by phenmetrazine abuse]. | 1970-01-01 |
|
| [Psychoses induced by phenmetrazine]. | 1969-07-01 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:25:24 GMT 2025
by
admin
on
Mon Mar 31 18:25:24 GMT 2025
|
| Record UNII |
6U85YRT588
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
1631
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
||
|
NCI_THESAURUS |
C29728
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
||
|
NCI_THESAURUS |
C47795
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
405728
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
92159
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
13580-35-3
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
DBSALT000705
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
m8621
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000085273
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
1707-14-8
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
C66373
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
216-950-6
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
203198
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | RxNorm | ||
|
CHEMBL1201208
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
DTXSID0047822
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
6U85YRT588
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY | |||
|
SUB03750MIG
Created by
admin on Mon Mar 31 18:25:24 GMT 2025 , Edited by admin on Mon Mar 31 18:25:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |